Anika Therapeutics (ANIK) Work In Process (2011 - 2018)

Anika Therapeutics (ANIK) has 8 years of Work In Process data on file, last reported at $5.9 million in Q3 2018.

• On a quarterly basis, Work In Process fell 9.38% year-over-year to $5.9 million in Q3 2018; TTM through Sep 2018 was $5.9 million, a 9.38% decrease from a year earlier, with the FY2017 full-year figure at $6.1 million, up 9.05% from the prior year.
• Work In Process for Q3 2018 stood at $5.9 million, down from $6.3 million in the prior quarter.
• Over the last five years, Work In Process for ANIK reached as high as $6.6 million in Q3 2017 and fell as low as $2.2 million in Q2 2014.
• Historically, Work In Process has averaged $4.8 million across 5 years, with a median of $5.6 million in 2016.
• Across the five-year window, Work In Process soared 94.43% in 2016 and dropped 9.38% in 2018, its largest moves.
• Year by year, Work In Process stood at $3.0 million in 2014, then soared by 85.99% to $5.7 million in 2015, then dropped by 1.71% to $5.6 million in 2016, then advanced by 9.05% to $6.1 million in 2017, then retreated by 1.88% to $5.9 million in 2018.
• Per Business Quant data, the three most recent Work In Process figures were $5.9 million in Q3 2018, $6.3 million in Q2 2018, and $5.9 million in Q1 2018.